Medical Specialty >> Gynecology
As More U.S. Women Delay Childbirth, Multiple Births May Rise
9:00 AM CDT.
Read article
- Scent of a Woman: Fertile Females Smell Better to Men
- Sexual Violence Haunts Women for Years
- Exercise Doesn’t Affect Timing of Menopause, Study Finds
- LGBT Americans Typically Poorer Than Straight Peers: Study
JOURNAL UPDATE
Active Choice Intervention Tied to Increase in Flu Shot Rates
7:00 PM CDT. Vaccination rates decrease throughout the day; with intervention, similar increase throughout day- Scribes Improve Physician Workflow, Patient Interaction
- Drug Prices Increase More Than Expected After Shortages
- Compliance With Requirement to Report Results on EUCTR Is Poor
MONTHLY JOURNAL SUMMARY
August 2018 Briefing - OBGYN & Women’s Health
September 04, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
Breast cancer
By Tamer M. Fouad, M.D. Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (11.9%…
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
